CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

← M89

Chapter 13 - Diseases of the musculoskeletal system and connective tissue (M00-M99)»Other osteopathies (M86-M90)»Hypertrophy of bone (M89.3)

M89.3

Hypertrophy of bone

Sub-codes (10)

  • M89.30 Hypertrophy of bone, unspecified site
  • M89.31 Hypertrophy of bone, shoulder
  • M89.32 Hypertrophy of bone, humerus
  • M89.33 Hypertrophy of bone, ulna and radius
  • M89.34 Hypertrophy of bone, hand
  • M89.35 Hypertrophy of bone, femur
  • M89.36 Hypertrophy of bone, tibia and fibula
  • M89.37 Hypertrophy of bone, ankle and foot
  • M89.38 Hypertrophy of bone, other site
  • M89.39 Hypertrophy of bone, multiple sites

Related indications (MeSH) (1)

Hyperostosis

Increase in the mass of bone per unit volume.

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.